An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype

English version České info

Epithelial-mesenchymal transition (EMT), a mechanism important for embryonic development, plays a critical role during malignant transformation. While much is known about transcriptional regulation of EMT, alternative splicing of several genes has also been correlated with EMT progression, but the extent of splicing changes and their contributions to the morphological conversion accompanying EMT have not been investigated comprehensively. Using an established cell culture model and RNA–Seq analyses, we determined an alternative splicing signature for EMT. Genes encoding key drivers of EMT–dependent changes in cell phenotype, such as actin cytoskeleton remodeling, regulation of cell–cell junction formation, and regulation of cell migration, were enriched among EMT–associated alternatively splicing events. Our analysis suggested that most EMT–associated alternative splicing events are regulated by one or more members of the RBFOX, MBNL, CELF, hnRNP, or ESRP classes of splicing factors. The EMT alternative splicing signature was confirmed in human breast cancer cell lines, which could be classified into basal and luminal subtypes based exclusively on their EMT–associated splicing pattern. Expression of EMT–associated alternative mRNA transcripts was also observed in primary breast cancer samples, indicating that EMT–dependent splicing changes occur commonly in human tumors. The functional significance of EMT–associated alternative splicing was tested by expression of the epithelial-specific splicing factor ESRP1 or by depletion of RBFOX2 in mesenchymal cells, both of which elicited significant changes in cell morphology and motility towards an epithelial phenotype, suggesting that splicing regulation alone can drive critical aspects of EMT–associated phenotypic changes. The molecular description obtained here may aid in the development of new diagnostic and prognostic markers for analysis of breast cancer progression.

Vyšlo v časopise: An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype. PLoS Genet 7(8): e32767. doi:10.1371/journal.pgen.1002218
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002218

Souhrn

Zdroje

1. ChristoforiG 2006 New signals from the invasive front. Nature 441 444 450

2. Vincent-SalomonAThieryJP 2003 Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5 101 106

3. YangJWeinbergRA 2008 Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14 818 829

4. YilmazMChristoforiG 2009 EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28 15 33

5. NelsonWJ 2008 Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem Soc Trans 36 149 155

6. CondeelisJPollardJW 2006 Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 263 266

7. ChristiansenJJRajasekaranAK 2006 Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66 8319 8326

8. AbbaMCDrakeJAHawkinsKAHuYSunH 2004 Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res 6 R499 513

9. SorlieTPerouCMTibshiraniRAasTGeislerS 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 10869 10874

10. ThompsonEWNewgreenDFTarinD 2005 Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65 5991 5995; discussion 5995

11. SabbahMEmamiSRedeuilhGJulienSPrevostG 2008 Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11 123 151

12. RubinMAPutziMMucciNSmithDCWojnoK 2000 Rapid (“warm”) autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 6 1038 1045

13. PolyakKWeinbergRA 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9 265 273

14. BlickTWidodoEHugoHWalthamMLenburgME 2008 Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25 629 642

15. HugoHAcklandMLBlickTLawrenceMGClementsJA 2007 Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. J Cell Physiol 213 374 383

16. ManiSAYangJBrooksMSchwaningerGZhouA 2007 Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 104 10069 10074

17. ThisseBel MessalMPerrin-SchmittF 1987 The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 15 3439 3453

18. YangJManiSADonaherJLRamaswamySItzyksonRA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 927 939

19. BlencoweBJ 2006 Alternative splicing: new insights from global analyses. Cell 126 37 47

20. WangETSandbergRLuoSKhrebtukovaIZhangL 2008 Alternative isoform regulation in human tissue transcriptomes. Nature 456 470 476

21. SrebrowAKornblihttAR 2006 The connection between splicing and cancer. J Cell Sci 119 2635 2641

22. SavagnerPVallesAMJouanneauJYamadaKMThieryJP 1994 Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 5 851 862

23. PinoMSBalsamoMDi ModugnoFMottoleseMAlessioM 2008 Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin Cancer Res 14 4943 4950

24. WarzechaCCSatoTKNabetBHogeneschJBCarstensRP 2009 ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33 591 601

25. KeirsebilckABonneSStaesKvan HengelJNolletF 1998 Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms. Genomics 50 129 146

26. LapukAMarrHJakkulaLPedroHBhattacharyaS Exon-level microarray analyses identify alternative splicing programs in breast cancer. Mol Cancer Res 8 961 974

27. YeoGWCoufalNGLiangTYPengGEFuXD 2009 An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol 16 130 137

28. WarzechaCCJiangPAmirikianKDittmarKALuH An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. Embo J 29 3286 3300

29. ManiSAGuoWLiaoMJEatonENAyyananA 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704 715

30. ShangYHuXDiRenzoJLazarMABrownM 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 843 852

31. Thierry-MiegDThierry-MiegJ 2006 AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1 S12 11

32. MortazaviAWilliamsBAMcCueKSchaefferLWoldB 2008 Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5 621 628

33. AudicSClaverieJM 1997 The significance of digital gene expression profiles. Genome Res 7 986 995

34. TaubeJHHerschkowitzJIKomurovKZhouAYGuptaS Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107 15449 15454

35. LaGambaDNawshadAHayED 2005 Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 234 132 142

36. ThomsonSPettiFSujka-KwokIMercadoPBeanJ A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28 137 155

37. XueYZhouYWuTZhuTJiX 2009 Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell 36 996 1006

38. YonedaTWilliamsPJHiragaTNiewolnaMNishimuraR 2001 A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16 1486 1495

39. RiazMElstrodtFHollestelleADehghanAKlijnJG 2009 Low-risk susceptibility alleles in 40 human breast cancer cell lines. BMC Cancer 9 236

40. MaasRABruningPFBreedijkAJTopBPeterseHL 1995 Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates. Lab Invest 72 760 764

41. WarzechaCCShenSXingYCarstensRP 2009 The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol 6 546 562

42. MoriMNakagamiHKoibuchiNMiuraKTakamiY 2009 Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell 20 3115 3124

43. JoslinEJOpreskoLKWellsAWileyHSLauffenburgerDA 2007 EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation. J Cell Sci 120 3688 3699

44. VitorinoPMeyerT 2008 Modular control of endothelial sheet migration. Genes Dev 22 3268 3281

45. EwaldAJBrenotADuongMChanBSWerbZ 2008 Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 14 570 581

46. BaldaMSWhitneyJAFloresCGonzalezSCereijidoM 1996 Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134 1031 1049

47. TroxellMLGopalakrishnanSMcCormackJPoteatBAPenningtonJ 2000 Inhibiting cadherin function by dominant mutant E-cadherin expression increases the extent of tight junction assembly. J Cell Sci 113 Pt 6 985 996

48. BolosVPeinadoHPerez-MorenoMAFragaMFEstellerM 2003 The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116 499 511

49. MediciDHayEDOlsenBR 2008 Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 19 4875 4887

50. BrownRLReinkeLMDamerowMSPerezDChodoshLA CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest

51. ChikumiHBaracABehbahaniBGaoYTeramotoH 2004 Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential. Oncogene 23 233 240

52. TerenziFLaddAN Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol 7

53. LinXMillerJWMankodiAKanadiaRNYuanY 2006 Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15 2087 2097

54. TerenziFLaddAN Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol 7 43 55

55. PhuaDCHumbertPOHunzikerW 2009 Vimentin regulates scribble activity by protecting it from proteasomal degradation. Mol Biol Cell 20 2841 2855

56. QinYCapaldoCGumbinerBMMacaraIG 2005 The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171 1061 1071

57. HusemannYGeiglJBSchubertFMusianiPMeyerM 2008 Systemic spread is an early step in breast cancer. Cancer Cell 13 58 68

58. GhignaCGiordanoSShenHBenvenutoFCastiglioniF 2005 Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20 881 890

59. ValaccaCBonomiSBurattiEPedrottiSBaralleFE Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191 87 99

60. OlteanSFebboPGGarcia-BlancoMA 2008 Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo. Clin Exp Metastasis 25 611 619

61. LiuRWangXChenGYDalerbaPGurneyA 2007 The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356 217 226

62. SheridanCKishimotoHFuchsRKMehrotraSBhat-NakshatriP 2006 CD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8 R59

63. PajaresMJEzpondaTCatenaRCalvoAPioR 2007 Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8 349 357

64. VenablesJPKlinckRBramardAInkelLDufresne-MartinG 2008 Identification of alternative splicing markers for breast cancer. Cancer Res 68 9525 9531

65. VenablesJPKlinckRKohCGervais-BirdJBramardA 2009 Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16 670 676

66. RobinsonBDSicaGLLiuYFRohanTEGertlerFB 2009 Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15 2433 2441

67. HeimannRHellmanS 2000 Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18 591 599

68. CreightonCJLiXLandisMDixonJMNeumeisterVM 2009 Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106 13820 13825

69. YangADFanFCampERvan BurenGLiuW 2006 Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12 4147 4153

70. KajiyamaHShibataKTerauchiMYamashitaMInoK 2007 Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 31 277 283

71. ElenbaasBSpirioLKoernerFFlemingMDZimonjicDB 2001 Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15 50 65

72. KimHDGuoTWWuAPWellsAGertlerFB 2008 Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell 19 4249 4259